BI 1819479

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 1819479, covering 2026-02-18 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How BI 1819479 is Taken up and Processed by the Body [Phase 1]